Butalbital, Acetaminophen, and Caffeine
- Product NDC
- 0143-0170
- 11-digit product format
- 001430170
- Labeler code
- 0143
- Product ID
- 0143-0170_d7673793-e24d-42ec-a984-2e73992fa8aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Butalbital, Acetaminophen, and Caffeine
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- West-Ward Pharmaceutical Corp
- Application
- ANDA040261
- Marketing category
- ANDA
- Marketing start
- 1998-10-28
- Marketing end
- 0000-00-00
- Substance
- BUTALBITAL; ACETAMINOPHEN; CAFFEINE
- Active strength
- 50 mg/1; mg/1; mg/1
- Pharmacologic classes
- Barbiturates [CS],Barbiturate [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0143-0170-01 | Butalbital, Acetaminophen, and Caffeine | 100 in 1 BOTTLE | CAPSULE | 100 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ACETAMINOPHEN | ACTIVE INGREDIENT | 362O9ITL9D | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| BUTALBITAL | ACTIVE INGREDIENT | KHS0AZ4JVK | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| CAFFEINE | ACTIVE INGREDIENT | 3G6A5W338E | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| ACETAMINOPHEN | ACTIVE MOIETY | 362O9ITL9D | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| BUTALBITAL | ACTIVE MOIETY | KHS0AZ4JVK | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| CAFFEINE | ACTIVE MOIETY | 3G6A5W338E | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| D&C RED NO. 33 | INACTIVE INGREDIENT | 9DBA0SBB0L | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0143-0170 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULE [WEST-WARD PHARMACEUTICAL CORP] | 1 | Legacy NDC, 1 package rows | 20131118_07b47cba-fadc-437e-9a9a-845ee1cce591.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 0143-0170-01 | 00143017001 | 100 in 1 BOTTLE | Historical |